856 | MARSUN, A PHASE III, MULTICENTER, OPEN LABEL, RANDOMIZED STUDY INVESTIGATING MOSUNETUZUMAB‐LENALIDOMIDE VERSUS INVESTIGATOR CHOICES IN R/R MARGINAL ZONE LYMPHOMASSylvain Carras, Catherine Thiéblemont, Stefano Luminari et al.|Hematological Oncology|2025Cited by 1